Poly-L-lysine/heparin stimulates angiogenesis in chick embryo chorioallantoic membrane

Biochemical and Biophysical Research Communications

Volumn 290, Issue 2, 2002, Pages 820-823

  Pacini, Stefania ^a   Gulisano, Massimo ^a   Vannucchi, Simonetta ^a   Ruggiero, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane assay; Glycosaminoglycans; Heparin

Indexed keywords

HEPARIN; HEPARIN BINDING PROTEIN; HEPARIN DERIVATIVE; HEPARIN POLYLYSINE; POLYLYSINE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHICKEN; CHORIOALLANTOIS; COMPLEX FORMATION; CONTROLLED STUDY; ELECTRICITY; EMBRYO; NONHUMAN; PRIORITY JOURNAL;

EID: 0036289405     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6254     Document Type: Article

References (17)

1. The complex effects of heparins on cancer progression and metastasis in experimental studies
2. Identification and dynamics of a heparin-binding site in hepatocyte growth factor
3. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
4. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma
5. Heparin binding peptides copurify with glycosaminoglycans from human plasma
6. Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass
7. Endogenous heparinase-sensitive anticoagulant activity in human plasma
8. Exogenous heparin induces fibronectin overexpression parallel to angiogenesis in the extracellular matrix of the chick embryo chorioallantoic membrane
9. Connective tissue growth factor induces proliferation, migration and tube formation of vascular endothelial cells in vitro and angiogenesis in vivo
10. Effects of cortisone with and without heparin on angiogenesis induced by prostaglandin-E1 and by S180 cells, and on growth of murine transplantable tumors
11. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone
12. Complexing of heparin with phosphatidylcholine. A possible supramolecular assembly of plasma heparin
13. The coronary angiogenetic effect of heparin: Experimental basis and clinical evidence
14. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for MET binding and signaling
15. Internalization and metabolism of endogenous heparin by cultured endothelial cells
16. Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: Altered potential of hepatocellular carcinoma heparan sulphate
17. Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus